- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03526952
An Internet Delivered Intervention for Re-Adjustment to Sexual Intimacy With an Ostomy After Cancer
8. März 2019 aktualisiert von: Sunnybrook Health Sciences Centre
This study investigates the feasibility and efficacy of an Internet-delivered intervention for the sexual and intimate re-adjustment of couples in which one partner is living with a temporary or permanent ostomy (e.g., colostomy, ileostomy, urostomy) following treatment for colorectal and/or bladder cancer.
The two session intervention will be delivered via online videoconferencing and will focus on facilitating couples' communication around their sexual and intimate relationship.
Exercises from sex therapy will be used to scaffold conversations about motivations for having sex, intimacy and sensual pleasure, and relational strengths for coping.
The intervention aims to enhance couples' ability to cope with the changes in their sexual and intimate relationship.
A group of couples receiving written educational material only will be used as a comparison group to measure change in sexual and intimate adjustment over time.
Studienübersicht
Status
Unbekannt
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Voraussichtlich)
60
Phase
- Unzutreffend
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
Ontario
-
Toronto, Ontario, Kanada
- Rekrutierung
- Sunnybrook Health Sciences Centre
-
Kontakt:
- Karen Fergus, PhD
- Telefonnummer: 81447 416-480-6100
- E-Mail: karen.fergus@sunnybrook.ca
-
Kontakt:
- Molly McCarthy, MA
- Telefonnummer: 81447 416-480-6100
- E-Mail: molly.mccarthy@sunnybrook.ca
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
18 Jahre und älter (Erwachsene, Älterer Erwachsener)
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion criteria:
Patients meeting all of the following criteria will be eligible for the study:
- Patients who have had a diagnosis of colorectal and/or bladder cancer within their lifetime
- Patients who are at least 1-month post active treatment for colorectal and/or bladder cancer
- Patients who have an ostomy due to colorectal and/or bladder cancer (e.g., colostomy, ileostomy, urostomy; permanent or temporary)
- Patients who are in a committed intimate relationship
- Patients who report changes in their sexual/intimate relationship associated with colorectal and/or bladder cancer and/or living with an ostomy
- Patients who have access to the Internet in a private space
- Patients who reside in Ontario
- Patients who are 18 years of age or older
OR
Partners of patients who meet the above criteria and who are 18 years of age or older
Exclusion criteria:
Patients/couples will be excluded from study participation if:
- Patient is undergoing active treatment for cancer
- Patient or partner report high levels of relational distress and would be better suited to couples therapy
- Couple is attending or plans to attend couples or sex therapy concurrently with participation in study
- Patient or partner is currently experiencing mental health concerns that would interfere with study participation (e.g., suicidal ideation, psychotic disorders, substance abuse, spousal abuse)
- Patient or partner lack English proficiency
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Sequenzielle Zuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Intervention Group
Couples in this group will receive the Internet-Delivered Intervention for Sexual Re-Adjustment
|
Couples will meet with a therapist via video-conferencing for two 1.5-hr sessions.
The therapist will facilitate couples' communication about their sexual and intimate relationship while providing psychoeducation about couple coping and sexuality after cancer and with an ostomy.
Discussion will focus on current concerns, motivations for sex, relational strengths, and intimacy and sensual pleasure.
Couples will also be encouraged to practice a sensate focusing exercise between sessions.
|
|
Aktiver Komparator: Educational Comparison Group
Couples in this group will receive only written educational material about sexuality and intimacy with an ostomy.
|
Couples will receive written educational material for patients coping with changes in intimacy and sexuality when living with a permanent ostomy.
This educational material is published by the United Ostomy Associations of America, Inc. and is available for free download from their website.
Couples will have two weeks to read this material.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in sexual functioning from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Sexual Functioning Questionnaire (SFQ): A measure sexual functioning developed specifically for cancer patients and their partners.
This measure includes 22 scored items and nine subscales related to different areas of concern (i.e., Interest, Desire, Arousal, Satisfaction, Activity, Orgasm, Masturbation, Relationship, and Problems).
For these subscales, higher scores represent better functioning.
The optional 5-item Health Impact Scale assess the impact of cancer on the patient's sexual functioning and can be adapted for the partner.
For the Health Impact subscale, higher scores represent greater impact.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in communication about sex from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Dyadic Sexual Communication Scale (DSC): The DSC scale is a 13-item scale that measures how respondents perceive the discussion of sexual matters with their partners.
Items are rated on a 6-point Likert type scale (1 = Disagree Strongly, 6 = Agree Strongly).
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in perceived self efficacy in coping with sexual and intimate changes from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Sexual Self-Efficacy: A 3-item questionnaire for assessing individual's perceived self-efficacy in coping with sexual and intimate change in the context of cancer.
Respondents rate their level of confidence in coping with these changes on a scale of 0-100 (0 = cannot do at all, 100 = highly certain can do).
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in relational identity or closeness from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
"We-ness" Questionnaire: A measure of the degree partner's perceive themselves more as being a unit ("we/us") than two separate identities ("I/me" or "you/him/her"), which encompassed an intertwined structure of affective, cognitive, and behavioural facets.
The questionnaire includes 16-items about facets of couples' mutual identity and respondents use a 5-point Likert scale to rate the degree to which these facets contribute to their sense of mutual identity in their current relationship.
Higher scores represent a greater sense of shared identity.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in mutual identity from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Inclusion of Other In Self Scale (IOSS): The IOSS is a one-item, visual measure of the degree to which one views one's partner as being part of one's self-concept.
Respondents choose one of seven Venn-diagram type images that represent varying degrees of mutual identity.
Higher scores represent greater degrees of self-other overlap in identity.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in relational adjustment from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Revised Dyadic Adjustment Scale: A 14-item self-report questionnaire measuring respondents' relational adjustment in terms of consensus, satisfaction, and cohesion.
Items are scaled on a 6-point Likert scale.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in psychological adjustment (depression) from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Centre for Epidemiological Studies Depression Scale- Revised (CESD-R): A brief 20-item self-report measure of depressive symptoms experienced over the past week.
Respondents indicate how often they have experienced the symptoms over the past week using a 5-point Likert scale.
Higher scores indicate higher risk for clinical depression.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Change in psychological adjustment (anxiety) from four different time points
Zeitfenster: This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Generalized Anxiety Disorder-7 (GAD-7): A brief, 7-item, self-report measure of generalized anxiety.
Respondents indicate how often they have experienced symptoms of generalized anxiety over the past two weeks, using a 4-point Likert scale.
Higher scores indicate greater levels of difficulty.
|
This questionnaire will be completed by participants at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Patients' change in adjustment to colorectal cancer from four different time points
Zeitfenster: This questionnaire will be completed by patients diagnosed with colorectal cancer at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Functional Assessment for Cancer Treatment - Colorectal Cancer (FACT-C): The "Colorectal Cancer" subscale of the FACT-C will be completed by patients only as a measure of their adjustment to the colorectal cancer and ostomy.
The subscale includes 9-items about physical and psychological symptoms related to colorectal cancer and respondents are to indicate the degree to which they experienced these symptoms in the past week using a 5-point Likert scale (0 = not at all, 5 = very much).
|
This questionnaire will be completed by patients diagnosed with colorectal cancer at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
|
Patients' change in adjustment to bladder cancer from four different time points
Zeitfenster: This questionnaire will be completed by patients diagnosed with bladder cancer at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Functional Assessment for Cancer Treatment - Bladder Cancer (FACT-Bl): The "Bladder Cancer" subscale of the FACT-Bl will be completed by patients only as a measure of their adjustment to the colorectal cancer and ostomy.
The subscale includes 9-items about physical and psychological symptoms related to bladder cancer and respondents are to indicate the degree to which they experienced these symptoms in the past week using a 5-point Likert scale (0 = not at all, 5 = very much).
|
This questionnaire will be completed by patients diagnosed with bladder cancer at T0 (baseline), T1 (within 1-week after intervention), T2 (1-month after intervention), and T3 (3-months after intervention)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Expectancy for Change
Zeitfenster: This questionnaire will be completed once at T0 (baseline)
|
Credibility/expectancy questionnaire: A brief 6-item measure of treatment expectancy and rationale credibility.
|
This questionnaire will be completed once at T0 (baseline)
|
|
Therapeutic Alliance
Zeitfenster: This questionnaire will be completed once at T1 (within 1-week after intervention)
|
Working Alliance Inventory Short Form-Revised (WAI-SR): The WAI-SR will be used to measure each participant's working alliance with the therapist facilitating the two session intervention.
The WAI-SR is a 12-item self-report measure of working alliance from the client's perspective that uses a 5-point Likert scale, where higher score represent better working alliance between client and therapist.
|
This questionnaire will be completed once at T1 (within 1-week after intervention)
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Ermittler
- Hauptermittler: Karen Fergus, PhD, C.Psych, Sunnybrook Health Sciences Centre
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
4. Mai 2018
Primärer Abschluss (Voraussichtlich)
31. August 2019
Studienabschluss (Voraussichtlich)
31. August 2019
Studienanmeldedaten
Zuerst eingereicht
10. April 2018
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
15. Mai 2018
Zuerst gepostet (Tatsächlich)
16. Mai 2018
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
12. März 2019
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
8. März 2019
Zuletzt verifiziert
1. März 2019
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 352-2016
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Unentschieden
Beschreibung des IPD-Plans
The study will be shared via publication(s) in an academic journal and/or conference presentation(s)
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Nein
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Nein
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .